Hofseth BioCare ASA (OSTO:HBCO) Total Liabilities : kr235.0 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Hofseth BioCare ASA Total Liabilities?

Hofseth BioCare ASA's Total Liabilities for the quarter that ended in Mar. 2024 was kr235.0 Mil.

Hofseth BioCare ASA's quarterly Total Liabilities increased from Sep. 2023 (kr307.93 Mil) to Dec. 2023 (kr348.98 Mil) but then declined from Dec. 2023 (kr348.98 Mil) to Mar. 2024 (kr235.05 Mil).

Hofseth BioCare ASA's annual Total Liabilities declined from Dec. 2021 (kr275.60 Mil) to Dec. 2022 (kr263.00 Mil) but then increased from Dec. 2022 (kr263.00 Mil) to Dec. 2023 (kr348.98 Mil).

Hofseth BioCare ASA Total Liabilities Historical Data

The historical data trend for Hofseth BioCare ASA's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA Total Liabilities Chart

Hofseth BioCare ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

175.26

195.37

275.60

263.00

348.98

Hofseth BioCare ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															278.62	294.29	307.93	348.98	235.05

Hofseth BioCare ASA Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hofseth BioCare ASA's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	251.877	+	(97.102	+	-2.8421709430404E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	349.0

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	390.119	-	41.14
	=	349.0

Hofseth BioCare ASA's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	139.714	+	(95.689	+	-0.35599999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	235.0

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	390.714	-	155.667
	=	235.0

Hofseth BioCare ASA Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hofseth BioCare ASA (OSTO:HBCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hofseth BioCare ASA (OSTO:HBCO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

HOFBF:USA HBC:Norway HBQ:Germany

Address

Kipervikgata 13, Aalesund, NOR, 6003

Website

https://www.hofsethbiocare.com

Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.

Hofseth BioCare ASA (OSTO:HBCO) Headlines

No Headlines